2022 Q4 Form 10-K Financial Statement

#000149315223010345 Filed on March 31, 2023

View on sec.gov

Income Statement

Concept 2022 Q4 2022
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $185.7K $666.3K
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $185.7K $666.3K
YoY Change 151334.32%
Operating Profit
YoY Change
Interest Expense $1.002M $100.0K
YoY Change
% of Operating Profit
Other Income/Expense, Net $1.677M
YoY Change
Pretax Income $815.9K $1.010M
YoY Change -229707.73%
Income Tax $310.3K $310.3K
% Of Pretax Income 38.03% 30.71%
Net Earnings $505.6K $700.0K
YoY Change -159194.32%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.04 $0.05
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $262.8K $262.8K
YoY Change 5155.2%
Cash & Equivalents $262.8K
Short-Term Investments
Other Short-Term Assets $157.6K $157.6K
YoY Change
Inventory
Prepaid Expenses $157.6K
Receivables
Other Receivables
Total Short-Term Assets $420.4K $420.4K
YoY Change 8307.4% 8307.4%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $119.0M $119.0M
YoY Change
Other Assets $77.65K $77.65K
YoY Change -42.68%
Total Long-Term Assets $119.1M $119.1M
YoY Change 87792.1% 87788.85%
TOTAL ASSETS
Total Short-Term Assets $420.4K $420.4K
Total Long-Term Assets $119.1M $119.1M
Total Assets $119.5M $119.5M
YoY Change 84962.55% 84959.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $130.2K $130.2K
YoY Change
Accrued Expenses $202.7K $202.7K
YoY Change 1251.4%
Deferred Revenue
YoY Change
Short-Term Debt $144.4K $144.4K
YoY Change 43.17%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $787.6K $787.6K
YoY Change 579.62% 579.64%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $3.450M $3.450M
YoY Change
Total Long-Term Liabilities $3.450M $3.450M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $787.6K $787.6K
Total Long-Term Liabilities $3.450M $3.450M
Total Liabilities $4.238M $4.238M
YoY Change 3556.51% 3556.61%
SHAREHOLDERS EQUITY
Retained Earnings -$3.230M
YoY Change 737275.34%
Common Stock $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$3.229M $115.2M
YoY Change
Total Liabilities & Shareholders Equity $119.5M $119.5M
YoY Change 84962.55% 84959.53%

Cashflow Statement

Concept 2022 Q4 2022
OPERATING ACTIVITIES
Net Income $505.6K $700.0K
YoY Change -159194.32%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$65.75K -$601.4K
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 -$117.3M
YoY Change
Cash From Investing Activities $0.00 -$117.3M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 $118.2M
YoY Change 2363082.22%
NET CHANGE
Cash From Operating Activities -65.75K -$601.4K
Cash From Investing Activities 0.000 -$117.3M
Cash From Financing Activities 0.000 $118.2M
Net Change In Cash -65.75K $257.8K
YoY Change 5055.12%
FREE CASH FLOW
Cash From Operating Activities -$65.75K -$601.4K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001889450
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
usd
CY2022Q4 us-gaap Deferred Costs
DeferredCosts
usd
CY2021Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
usd
CY2021Q4 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
usd
CY2021Q4 FTIIU Franchise Tax Payable Current
FranchiseTaxPayableCurrent
usd
CY2021Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
usd
CY2021Q4 FTIIU Deferred Underwriting Commission
DeferredUnderwritingCommission
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
usd
us-gaap Administrative Fees Expense
AdministrativeFeesExpense
usd
FTIIU Franchise Tax
FranchiseTax
usd
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
usd
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
usd
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Proceeds From Sale Of Interest In Partnership Unit
ProceedsFromSaleOfInterestInPartnershipUnit
usd
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
usd
us-gaap Repayments Of Accounts Receivable Securitization
RepaymentsOfAccountsReceivableSecuritization
usd
us-gaap Proceeds From Accounts Receivable Securitization
ProceedsFromAccountsReceivableSecuritization
usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
FTIIU Deferred Underwriting Commission Non Cash
DeferredUnderwritingCommissionNonCash
usd
CY2022 FTIIU Accrued Deferred Offering Costs
AccruedDeferredOfferingCosts
usd
FTIIU Initial Classification Of Class Common Stock Subject To Redemption
InitialClassificationOfClassCommonStockSubjectToRedemption
usd
FTIIU Remeasurement Adjustment
RemeasurementAdjustment
usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
usd
CY2022 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
usd
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-41289
CY2022 dei Entity Registrant Name
EntityRegistrantName
FUTURETECH II ACQUISITION CORP.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-2551539
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
128 Gail Drive
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
New Rochelle
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10805
CY2022 dei City Area Code
CityAreaCode
(914)
CY2022 dei Local Phone Number
LocalPhoneNumber
316-4805
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
true
CY2022Q2 dei Entity Public Float
EntityPublicFloat
114885000 usd
CY2022 dei Auditor Firm
AuditorFirmId
3686
CY2022 dei Auditor Name
AuditorName
Adeptus Partners, LLC
CY2022 dei Auditor Location
AuditorLocation
Ocean, New Jersey
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
262756 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5000 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
157614 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
420370 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
5000 usd
CY2021Q4 us-gaap Deferred Costs
DeferredCosts
135455 usd
CY2022Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
118976585 usd
CY2022Q4 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
77654 usd
CY2022Q4 us-gaap Assets
Assets
119474609 usd
CY2021Q4 us-gaap Assets
Assets
140455 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
130225 usd
CY2022Q4 FTIIU Franchise Tax Payable Current
FranchiseTaxPayableCurrent
200000 usd
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
310259 usd
CY2022Q4 FTIIU Accrued Offering Costs Current
AccruedOfferingCostsCurrent
2708 usd
CY2021Q4 FTIIU Accrued Offering Costs Current
AccruedOfferingCostsCurrent
15000 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
144443 usd
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
100893 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
787635 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
115893 usd
CY2022Q4 FTIIU Deferred Underwriting Commission
DeferredUnderwritingCommission
3450000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
4237635 usd
CY2021Q4 us-gaap Liabilities
Liabilities
115893 usd
CY2022Q4 FTIIU Common Stock Subject To Possible Redemption Shares
CommonStockSubjectToPossibleRedemptionShares
11500000 shares
CY2022Q4 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.30
CY2021Q4 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.30
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
118466326 usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24712 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3229704 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-438 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-3229352 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
24562 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
119474609 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
140455 usd
CY2022 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
100000 usd
CY2022 FTIIU Franchise Tax
FranchiseTax
200000 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
366311 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
438 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
666311 usd
us-gaap Operating Expenses
OperatingExpenses
438 usd
CY2022 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
1676585 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1676585 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1010274 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-438 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
310259 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
700015 usd
us-gaap Net Income Loss
NetIncomeLoss
-438 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
25000 usd
us-gaap Net Income Loss
NetIncomeLoss
-438 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
24562 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
24562 usd
CY2022 FTIIU Sale Of Units In Initial Public Offering Net Of Offering Costs
SaleOfUnitsInInitialPublicOfferingNetOfOfferingCosts
115000000 usd
CY2022 FTIIU Offering Costs
OfferingCosts
-2239502 usd
CY2022 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
5200750 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
3450000 usd
CY2022 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
-117300000 usd
CY2022 FTIIU Adjustment To Additional Paid In Capital Remeasurement Adjustment
AdjustmentToAdditionalPaidInCapitalRemeasurementAdjustment
-1166327 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
700015 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
700015 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-3229352 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-3229352 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
700015 usd
us-gaap Net Income Loss
NetIncomeLoss
-438 usd
CY2022 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
1676585 usd
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
157614 usd
CY2022 FTIIU Increase Decrease In Franchise Tax Payable
IncreaseDecreaseInFranchiseTaxPayable
200000 usd
CY2022 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
310259 usd
CY2022 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
77654 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
100225 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
438 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-601354 usd
CY2022 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
117300000 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-117300000 usd
CY2022 us-gaap Proceeds From Sale Of Interest In Partnership Unit
ProceedsFromSaleOfInterestInPartnershipUnit
115000000 usd
FTIIU Proceeds From Issuance Of Class B Common Stock To Sponsor
ProceedsFromIssuanceOfClassBCommonStockToSponsor
25000 usd
CY2022 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
5200750 usd
CY2022 FTIIU Uw Fee Paid
UwFeePaid
-1725000 usd
CY2022 us-gaap Repayments Of Accounts Receivable Securitization
RepaymentsOfAccountsReceivableSecuritization
100000 usd
CY2022 us-gaap Proceeds From Accounts Receivable Securitization
ProceedsFromAccountsReceivableSecuritization
100000 usd
CY2022 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
316640 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
20000 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
118159111 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5000 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
257756 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
262756 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5000 usd
CY2022 FTIIU Deferred Underwriting Commission Non Cash
DeferredUnderwritingCommissionNonCash
3450000 usd
FTIIU Accrued Deferred Offering Costs
AccruedDeferredOfferingCosts
15000 usd
CY2022 FTIIU Initial Classification Of Class Common Stock Subject To Redemption
InitialClassificationOfClassCommonStockSubjectToRedemption
118553638 usd
CY2022 FTIIU Remeasurement Adjustment
RemeasurementAdjustment
3929281 usd
CY2022 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
187993 usd
us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
100893 usd
CY2022Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
520075 shares
CY2022Q1 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
117300000 usd
CY2022Q1 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
10.00
CY2022Q4 FTIIU Cash Underwriting Fees
CashUnderwritingFees
1725000 usd
CY2022Q4 FTIIU Deferred Underwriting Commission
DeferredUnderwritingCommission
3450000 usd
CY2022Q4 us-gaap Other Deferred Costs Net
OtherDeferredCostsNet
513352 usd
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
700000 usd
CY2022Q4 FTIIU Percentage Of Aggregate Fair Market Value Of Assets
PercentageOfAggregateFairMarketValueOfAssets
0.80 pure
CY2022Q4 FTIIU Shares Redemptionof Business Combination Not Completed
SharesRedemptionofBusinessCombinationNotCompleted
0.50 pure
CY2022Q4 us-gaap Deposits
Deposits
1150000 usd
CY2022Q4 us-gaap Share Price
SharePrice
0.10
CY2022 us-gaap Interest Expense
InterestExpense
100000 usd
CY2022Q4 us-gaap Share Price
SharePrice
0.10
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
262756 usd
CY2022Q4 FTIIU Working Capital
WorkingCapital
367265 usd
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_841_eus-gaap--UseOfEstimates_zSolEsGlw9V7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_863_zZob0MC2Nllk">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_843_eus-gaap--ConcentrationRiskCreditRisk_zYSjyftZEhff" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_869_zhqGRsMO2AA4">Concentration of Credit Risk</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal depository insurance coverage of $<span id="xdx_90A_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_c20221231_zc3DswuCujeg" title="Cash FDIC insured amount">250,000</span>. At December 31, 2022, the Company had not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
262756 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5000 usd
CY2022 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
117300000 usd
CY2022Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
10.00
CY2022Q4 us-gaap Assets Held In Trust
AssetsHeldInTrust
118976585 usd
CY2022Q4 us-gaap Temporary Equity Aggregate Amount Of Redemption Requirement
TemporaryEquityAggregateAmountOfRedemptionRequirement
118466326 usd
CY2022 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
3929281 usd
CY2022Q4 us-gaap Assets Held In Trust
AssetsHeldInTrust
118976585 usd
CY2022Q3 FTIIU Percentage Of Exercise Tax To Be Imposed
PercentageOfExerciseTaxToBeImposed
0.01 pure
CY2022Q3 FTIIU Percentage Of Exercise Tax To Be Imposed
PercentageOfExerciseTaxToBeImposed
0.01 pure
CY2022 FTIIU Administrative Periodic Expense
AdministrativePeriodicExpense
10000 usd
CY2022 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
100000 usd
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 FTIIU Common Stock Subject To Possible Redemption Shares
CommonStockSubjectToPossibleRedemptionShares
11500000 shares
CY2021Q4 FTIIU Common Stock Subject To Possible Redemption Shares
CommonStockSubjectToPossibleRedemptionShares
0 shares
CY2022 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.20 pure
CY2022Q4 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P5Y
CY2022Q4 FTIIU Startup Costs
StartupCosts
98101 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
98101 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
98101 usd
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
310259 usd
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
98101 usd
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
98101 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
310259 usd
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
98101 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210 pure
CY2022 FTIIU Effective Valuation Allowance
EffectiveValuationAllowance
-0.098 pure
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.308 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
ftiiu-20221231_cal.xml Edgar Link unprocessable
0001493152-23-010345-index-headers.html Edgar Link pending
0001493152-23-010345-index.html Edgar Link pending
0001493152-23-010345.txt Edgar Link pending
0001493152-23-010345-xbrl.zip Edgar Link pending
ex21-1.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
ex4-5.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-k.htm Edgar Link pending
form10-k_001.jpg Edgar Link pending
ftiiu-20221231.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
ftiiu-20221231_def.xml Edgar Link unprocessable
ftiiu-20221231_lab.xml Edgar Link unprocessable
ftiiu-20221231_pre.xml Edgar Link unprocessable
form10-k_htm.xml Edgar Link completed
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending